Clinical trial NCT05674591: Cognitive Processing Therapy in Syrian Women Exposed to IPV
Official title: Cognitive Processing Therapy for the Treatment of Depression, Anxiety, PTSD, and Difficulties in Emotion Regulation in Syrian Females Exposed to Intimate Partner Violence
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Depression
Anxiety
PTSD
Keywords: Cognitive Processing Therapy
Syrian women
Mental health
Lead sponsor: British University In Egypt
Sponsor class: OTHER
First posted: 2023-01-06
Enrollment: 30
Sex: FEMALE
Minimum age (years): 16
Maximum age (years): 65
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NA
Intervention model: SINGLE_GROUP
Intervention model description: The current study is a clinical trial, including the repeated assessments of a single sample of Syrian women. Pre-treatment, posttreatment and 12-month posttreatment assessments were conducted on participants. PTSD severity, depression, anxiety and difficulties in emotion regulation will be assessed as outcomes.
Primary purpose: TREATMENT

Brief summary: This study aims to explore the efficacy of cognitive processing therapy (CPT) in treating depression, anxiety, PTSD, and difficulties with emotion regulation in Syrian females who have suffered intimate partner violence (IPV). Clinicians will conduct interviews with women and request that they complete the CAPS, Beck Depression Inventory II, Beck Anxiety Inventory, and DERS during pretreatment, posttreatment, and at the 12-month follow-up

Detailed description: This study aims to explore the efficacy of cognitive processing therapy (CPT) in treating depression, anxiety, PTSD, and difficulties with emotion regulation in Syrian females who have suffered intimate partner violence (IPV). Clinicians will conduct interviews with women and request that they complete the CAPS, Beck Depression Inventory II, Beck Anxiety Inventory, and DERS during pretreatment, posttreatment, and at the 12-month follow-up. Cognitive processing therapy (CPT) may have a substantial therapeutic benefit in the treatment of depression, anxiety, PTSD, and difficulties in emotion regulation among Syrian females who have suffered intimate partner violence.

Eligibility criteria: Inclusion Criteria:

* being a Syrian female who currently exposes to intimate partner violence,
* lives in Egypt
* has a good knowledge of English language because all assessments and therapy materials are in English.

Exclusion Criteria: having:

* cognitive difficulties
* schizophrenia (or any other psychotic disorders).

Primary outcomes:
measure: Women's Health and Domestic Violence against Women questionnaire
timeFrame: At first interview, pretreatment
measure: Change from Baseline on Clinician-Administered PTSD Scale at 3 months and at 12 months
timeFrame: baseline (pre-intervention), posttreatment (immediately after the intervention, an average of 3 months), 12-months after the intervention
measure: Change from Baseline on Beck Depression Inventory II scores at 3 months and at 12 months
timeFrame: baseline (pre-intervention), posttreatment (immediately after the intervention, an average of 3 months), 12-months after the intervention
measure: Change from Baseline on Beck Anxiety Inventory scores at 3 months and at 12 months
timeFrame: baseline (pre-intervention), posttreatment (immediately after the intervention, an average of 3 months), 12-months after the intervention
measure: Change from Baseline on Difficulties Emotion Regulation scale scores at 3 months and at 12 months
timeFrame: baseline (pre-intervention), posttreatment (immediately after the intervention, an average of 3 months), 12-months after the intervention
Secondary outcomes:
Other outcomes:
Locations:
city: Cairo
country: Egypt
facility: The British university in Egypt
Study officials:
affiliation: The British University in Egypt
name: Amani Elbarazi, PhD
role: PRINCIPAL_INVESTIGATOR
References: